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Aim To evaluate the knowledge, motivation, and attitudes 
of Hungarian family physicians toward pandemic influenza 
vaccination in the 2009/10 influenza season.
Method A questionnaire with 20 questions was devel-
oped and sent to 232 family physicians in 3 largest Hun-
garian cities: Budapest, Debrecen, and Miskolc. The study 
was conducted in December 2009 and January 2010.
Results A hundred and ninety eight (85%) physicians an-
swered  the  questionnaire  adequately.  Respondents  be-
lieved that the influenza outbreak represented less of a 
threat to their practices than to Hungary or the world as 
a whole. They mostly agreed that vaccination was impor-
tant and were frequently dissatisfied with the support from 
health authorities. The proportion of vaccinated patients 
ranged between 2% and 53%, without differences accord-
ing to geographical region, age, sex, and duration of physi-
cians’ employment in family practice. Physicians who were 
satisfied with the payment for procedures and underwent 
vaccination themselves were more active in vaccination.
Conclusion Health authorities should provide clear and 
evidence-based professional support to family physicians 
and  should  encourage  them  to  get  vaccinated  against 
pandemic influenza, while insurance funds have to estab-
lish appropriate reimbursement system.
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In June 2009, the World Health Organization (WHO) an-
nounced  the  global  pandemic  of  influenza  A/California 
07/09 (H1N1). In Hungary, the media and the leading Hun-
garian medical journal reported on the emergence of a 
novel strain of swine-origin virus (1). The symptoms were 
usually mild and prevention was important, with an em-
phasis on the adherence to hygiene and vaccination that 
was recommended for everyone at risk of becoming ill 
or of transmitting the virus. It was not recommended for 
pregnant women in the first trimester, due to a lack of ex-
perience with the vaccine in this population. The pandem-
ic had been predicted by infectologists years before (2,3).
The Hungarian government established the Committee for 
Pandemic, and family physicians were ordered to prepare 
weekly surveillance reports and lists of people who need-
ed vaccinations. Posters on personal hygiene and behavior 
recommendations were displayed in public spaces (4) and 
at the end of the summer of 2009 thermo-gates were de-
ployed at airports to detect incoming people with fever.
Vaccination was provided free of charge for health care 
staff, inpatients in hospitals and nursing homes, people 
over 60 years of age, patients with chronic pulmonary or 
heart diseases, children and adults who were assumed to 
be in danger of infection, police officers, workers of the 
public transport and services, and patients on long-term 
aspirin treatment (2).
Influenza AH1N1 variant arrived in Hungary in July 2009 
(2,5). The Hungarian Fluval P (Omninvest, Pilisborosjenő, 
Hungary) vaccine was developed as a brand of the previ-
ously used Fluval H5N1 vaccine, containing thiomersal as 
preservative agent (6), which was added to other vaccines 
used in the USA as well (7). Clinical evaluation in Hungary 
started in August in line with the European Union regula-
tions (8). After some modifications, the pharmaceutical au-
thority allowed its use in adolescents and later in children.
During the initial weeks, there were logistical problems 
with vaccine distribution. The vaccine was delivered by the 
local offices of the Chief Health Officer. For those who were 
vaccinated free of charge, the Hungarian Health Insurance 
Fund offered HUF 200 (cca € 0.75) extra payments to fam-
ily physicians per injection. For those who were not vacci-
nated free of charge, the price was HUF 1000-1500 (€ 4-6) 
per injection.
Through September and October 2009, lay press reported 
on a disagreement between experts on the safety and ef-
fectiveness of the vaccine. The most frequently discussed 
problem was the vaccination of pregnant women and chil-
dren (1,3).
Many family physicians lacked confidence in the vaccine 
and asked the patients to sign that they assume the respon-
sibility for any side effects or complications. This practice 
was supported by the Medical Chamber and other profes-
sional organizations, but was prohibited by the Minister of 
Health. One of the patient organizations pressed charges 
against the government (9). There were family physicians 
who recommended the vaccination and others who dis-
suaded their patients from getting vaccinated. The issue 
whether to start an antiviral treatment with neuraminidase 
inhibitors was also widely discussed (10,11).
For people who were vaccinated free of charge, a network 
of “vaccination-points” was organized by mid-November 
2009 in the county offices of the health authority and in 
larger hospitals. At these points, the whole reimbursement 
was HUF 3000 ( ≈ € 11), covering the price of the vaccine 
and the procedure. However, some suspicions over the fi-
nancial management of these points were raised (12).
Different opinions on the effectiveness of the vaccine were 
published  in  daily  newspapers  and  media  broadcasts. 
Some opposition politicians suggested that key govern-
ment officials were among the owners of the vaccine man-
ufacturer (13). Many of the opposition politicians refused 
to be vaccinated, while prominent government members, 
including the Minister of Health, underwent vaccination in 
a highly publicized manner.
In the mid-December, there were reports on deaths of 
mothers and their newborns attributable to H1N1. The 
position of the strongest opposition party toward vacci-
nation then changed and the party opened its own “vac-
cination point” in the center of Budapest (14). One of the 
leading opposition politicians blamed the government 
for buying the cheaper vaccine (13). In October, 73% of 
the polled were against the vaccination and in Novem-
ber only 57% were against it, while 28% supported the 
vaccination  and  15%  hesitated.  By  mid-December,  the 
ratio of vaccinated people was two times higher among 
the government supporters than among opposition sup-
porters (13,15).
The aim of this study was to evaluate the knowledge, mo-
tivation, and attitudes of family physicians regarding vac-
cination in the 2009/10 pandemic influenza season.PANDEMIC INFLUENZA 136 Croat Med J. 2011; 52: 134-40
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MEtHodS
After discussions with family physicians and public health 
experts, a questionnaire was developed, with 20 ques-
tions in Hungarian language (web extra material). There 
were 16 multiple-choice questions, 2 open-ended ques-
tions inquiring about general data on family practices 
and  vaccination-related  activities,  and  2  open-ended 
questions on respondents’ personal experiences and rec-
ommendations for the future. For some questions, more 
than one answer was accepted. The questionnaires were 
distributed during continuing medical education courses 
and other meetings of family physicians in Budapest and 
other two largest Hungarian cities, Debrecen and Miskolc, 
between December 2009 and January 2010. Participating 
physicians worked in these and surrounding smaller cit-
ies and rural areas.
The questions, answers, and their distribution are present-
ed in the order they appeared in the questionnaire. Results 
from the cities are reported together, except when signifi-
cant differences were found between them.
The statistical analysis was performed by Stata 8.2 software 
(Statacorp LP, College Station, TX, USA). Fisher exact test, 
Mann-Whitney test, and Kruskal-Wallis equality of popula-
tions rank tests were used. The level of significance was set 
at P < 0.05.
RESuLtS
Out of 232 distributed questionnaires, 198 were collected 
and analyzed (response rate: 85%). The mean time ± stan-
dard deviation duration of respondents’ employment in 
medical practice was 22.4 ± 12.1 years. Sixty one percent of 
respondents were male.
Physicians believed that the pandemic threat was greater 
for the whole world than for the Hungarian population 
or their own practice population (Table 1). Twenty of 30 
physicians  from  Budapest  (66.6%)  considered  vaccina-
tion as the most effective way of influenza prevention, as 
well as 89% of physicians from other two cities (103 of 
116 in Debrecen and 46 of 52 in Miskolc) (P = 0.09, Fisher 
exact test). Thirty four (29.7%) physicians from Debrecen 
believed  that  pharmaceutical  companies  were  behind 
the media campaign, which is significantly more than 2 
physicians from Budapest (6.7%) (P = 0.039, Fisher exact 
test). Physicians believed that they were much better 
informed on the issues related to H1N1 vaccination 
than the general public (Table 2). Respondents reported 
that they more frequently received information on the 
pandemics from the media than from the Health Ministry 
and the Insurance Fund, with whom they were profes-
sionally contracted (Table 3). Regarding logistic problems 
experienced during the first weeks of the campaign, phy-
sicians criticized pharmacists for not ordering and selling 
the vaccine. Most of the respondents considered the pa-
per-work associated with the vaccinations to be exagger-
ated and often superfluous. At the same time, there was 
tabLE 1. Family physicians’ (n = 198) estimation of pandemic 
threat for different populations
threat of pandemic 
influenza for
No (%) of physicians 
who answered the question
the population in extreme serious medium moderate none
the whole world 18 (9.1) 83 (41.9) 71 (35.9) 26 (13.1) 0
Hungary 11 (5.6) 74 (37.4) 76 (38.4) 37 (18.7) 0
your practice   5 (2.5) 55 (27.8) 82 (40.9) 51(25.8) 5(2.5)
tabLE 2. Family physicians’ (n = 198) opinion on preventive 
measures, media publicity, and how informed the general 
public and physicians are of influenza
Question
No. (%) of physicians 
who answered 
the question
What is the best way to prevent the 
pandemic influenza more effectively?*
vaccination 170 (86.1)
closing borders     5 (2.5)
local quarantine     5 (2.5)
hygienic regulations   75 (38.0)
How proportional is the media publicity 
to the real danger? *
proportional   25 (12.6)
too big 134 (67.7)
prompted by the pharmaceutical 
companies
  42 (21.2)
too small     5 (2.5)
How informed is the Hungarian popula-
tion about the danger of influenza?
sufficiently   25 (12.6)
partially   83 (41.9)
poorly   77 (38.9)
uninformed   13 (6.6)
How informed are the Hungarian 
family physicians’ about the danger 
of influenza?
sufficiently   90 (45.4)
partially   77 (38.9)
poorly   31 (15.7)
uninformed   0
*More than one answer was possible.137 Rurik et al: Knowledge, motivation, and attitudes of Hungarian family physicians toward pandemic influenza vaccination
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general satisfaction with the payment received for the 
procedures (Table 4).
On the scale from 1 (low) to 5 (high), the safety of the Hun-
garian vaccine was rated with 5 by 65 (36.2%) respondents, 
with 4 by 89 (45%), with 3 by 22 (11%), with 2 by 6 (3.2%), 
and with 1 by 6 (3.2%). On the same scale, the reliability of 
the Hungarian vaccine was rated with 5 by 90 (46%) re-
spondents, with 4 by 70 (36%), with 3 by 24 (12%), with 2 
by 4 (2.1%), and with 1 by 6 (3.1%).
Hundred  and  sixteen  physicians  (59%)  registered  only 
mild, transient adverse events in their patients following 
vaccination,  and  79  (40%)  did  not  register  any  adverse 
event. The mean percentage ± standard deviation of mi-
nor reactions was 11.0 ± 8.2 in Budapest, 2.3 ± 1.8 in Debre-
cen, and 1.5 ± 1.3 in Miskolc (P = 0.045, Kruskal-Wallis test). 
There were 11.0 ± 8.2% minor reactions in Budapest, which 
is higher than in both Debrecen (2.3 ± 1.8%) and Miskolc 
(1.5 ± 1.3%) (P = 0.045, Kruskal-Wallis test). A hundred and 
eighty eight (95%) physicians gave more than 100 injec-
tions during the process of immunization and 99 (50%) be-
tween 200 and 400. There was a wide gap between prac-
tices regarding the proportion of vaccinated people. This 
proportion varied between 2% and 53% of practice popu-
lations (median, 15%; inter-quartile range, 10-22%), with-
out differences in geographical location.
The 143 physicians who were vaccinated themselves had a 
median of practice vaccination of 18% (inter-quartile range, 
12%-22%), while the 55 physicians who were not vaccinat-
ed had 13% (inter-quartile range, 8-20%) (P = 0.046, Mann-
Whitney test). Physicians who considered the payment for 
the procedures proportional or correct were significantly 
more active in the vaccination than those who thought 
that it was only clearly determined (P = 0.017, Kruskal-Wallis 
test). There were no differences in sex of physicians and du-
ration of employment in the practice between physicians 
in all 3 cities.
In the questionnaire, physicians had the opportunity to 
give comments or recommendation for the future. Sev-
enty eight physicians recommended better organization 
by official bodies and giving more information to family 
physicians. Many of the respondents (69%) were upset 
by the politicians’ influence on the professional issues. 
Seventy-four percent thought that the media influ-
tabLE 3. Family physicians’ (n = 198) opinions on the contribu-
tion of different institutions to the vaccination campaign*
Question
No. (%) of physicians 
who answered the 
question
From whom did the physicians get the 
most useful information?
Ministry of Health   33 (16.7)
Chief Health Officer 152 (76.8)
Health Insurance Fund   25 (12.6)
media   74 (37.3)
Who should have provided more 
information to the population?
Ministry of Health 124 (62.6)
Chief Health Officer   93 (47.0)
Health Insurance Fund   29 (14.7)
media   49 (24.8)
Who’s performance was worse than 
expected?
Ministry of Health 108 (54.6)
Chief Health Officer 112 (56.6)
Primary care staff   48 (24.2)
pharmacists     6 (3.0)
Who should have gotten more tasks in 
vaccine administration?
Ministry of Health 110 (55.6)
Chief Health Officer   99 (50.0)
Primary care staff     9 (4.6)
pharmacists   16 (8.1)
*For all the questions, more than one answer was possible.
tabLE 4. Family physicians’ (n = 198) opinion on the admin-
istration of vaccination, payment to physicians, and self-
vaccination
Question
No. (%) of physicians 
who answered 
the question
Was the administration of vaccination:
proportional   27 (13.6)
bureaucratic 116 (58.6)
too complicated   51 (25.8)
simple     4 (2.0)
Was the payment to physicians:
proportional   79 (40.0)
correct   71 (35.9)




pneumococcal     7 (3.5)
other     1 (0.5)
none   44 (22.2)PANDEMIC INFLUENZA 138 Croat Med J. 2011; 52: 134-40
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ence was too strong and that the media inaccurately re-
ported on politicians’ and experts’ statements.
dIScuSSIoN
Hungarian physicians who believed in the effect of immu-
nization and were satisfied with financial incentives were 
more active in the pandemic influenza vaccination cam-
paign in the season 2009/2010. Physicians had no previous 
experiences in managing an epidemic and they had huge 
expectations from professional bodies and authorities, so 
initial logistic and organizational failures, accompanied by 
contradictive information arising from the political debate 
and media campaigns on the influenza, created uncertain-
ty and confusion among them.
As far as patients are concerned, it seems that they pre-
ferred the guidance of their favorite politician to that of 
their health care professionals (13,15). Also, different lev-
els of self-vaccination among physicians, as reported in our 
study, might have contributed to the lack of trust among 
patients, since they expect from health care professionals 
to be exemplary persons (11).
A limitation of our study is that it covered a small sample of 
family physicians, which has not been confirmed to be rep-
resentative. Furthermore, possible changes in their vaccina-
tion-related activity during the campaign were not evaluat-
ed, although they may have been influenced by the general 
public atmosphere in Hungary in the winter of 2009/2010 
(13-15). Also, they may have been influenced by acceptance 
of payments from the patients and from the Health Insur-
ance Fund, but that issue was not assessed in our study.
There  are  other  European  countries  in  which  problems 
with  vaccination  were  reported.  In  Germany  a “perfect 
chaos” was caused by different recommendations – poli-
ticians and soldiers got a presumably better type of vac-
cine than the largest part of the population (16). The indi-
cation was the same, but different schemes for injections 
and vaccines were provided by well-known multinational 
companies. Spanish experts were skeptical about the use 
of vaccination. They thought it to be irrational and based 
on fear-mongering rather than on “common sense and self 
control” (17). In the UK, the greatest problem, as perceived 
by the surveyed family physicians, were unclear, duplicate, 
and conflicting pieces of information (18).
Another important issue in Hungary was a profession-
al disagreement on the immunization during preg-
nancy. In other countries, pregnant women were recom-
mended seasonal influenza vaccination and identified as 
a priority group in the event of a pandemic. Vaccination 
in any trimester during the pandemic is supported by ex-
cess morbidity and mortality in the two previous influenza 
pandemics (19,20), as well as confirmed by recent WHO 
guidelines (21).
The viral or virion origin of vaccine and added preserva-
tive agents were very different worldwide. Because of the 
imminent pandemic threat there were countries, even in 
Europe, where detailed clinical tests were not carried out 
with the new vaccine. Only limited data on safety and im-
munogenicity of influenza A/H1N1 vaccines were available 
when EU member states started using them (22).
The present pandemic vaccine used in Hungary proved 
safe and immunogenic in healthy adults and the elderly. It 
could be safely co-administered with the 2009/10 seasonal 
influenza vaccine (8). Physicians using this vaccine in our 
study had similar experiences.
Not only physicians, but also the patients needed more in-
formation before making a decision about vaccination. The 
Hungarian Health Insurance Fund did not provide a infor-
mational leaflet for patients, while the informational leaflet 
of the National Health Services had already been available 
in the summer of 2009 (23).
At the end of March, it became clear that the epidemic had 
not been not as serious as anticipated. The obligation to 
send weekly a report to the Health Officer was abolished 
and “vaccination points” were closed. The government or-
dered 6 million vaccines for a population of 10 million. Four 
million were offered for free and 2 million were reimbursed 
by the patients. Large amount of ordered vaccine was not 
used. According to the recent available data, 3.34 million 
doses of vaccine were used, 1.3 million were given to the 
high-risk population for free, and 129 000 to health staff. 
A hundred and twenty nine fatalities were reported as a 
consequence of the pandemic and 1 as a consequence of 
seasonal influenza (24). The H1N1-related mortality in Hun-
gary was among the highest in Europe, but this could be 
explained by the precise laboratory and pathological ex-
amination after each death (25,26).
In the past few months, information about the relation be-
tween pharmaceutical companies, WHO experts, and vac-
cination advisors has been published (27). Many of the sur-
veyed Hungarian physicians had similar suspicion.139 Rurik et al: Knowledge, motivation, and attitudes of Hungarian family physicians toward pandemic influenza vaccination
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In other countries, discussions and arguments were mainly 
professional, typically not influenced by politicians (16-18). 
In Hungary, however, poor or inappropriate communica-
tion  with  the  government,  animosity  between  political 
parties, logistic and organizational failures at the outset 
of the campaign, and the lack of confidence in the gov-
ernmental institutions could have caused the confusion 
among physicians (13). These factors were combined with 
the hysteria initiated and maintained by the media (28).
Health  authorities  should  provide  clear  and  evidence-
based  professional  support  for  family  physicians  and 
should  encourage  self-vaccination  of  physicians,  while 
insurance funds have to establish appropriate reimburse-
ment system. Authors hope that their experiences can pre-
pare other primary care systems for any infectious threat 
in the future.
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